O
TMO icon

Ossiam’s Thermo Fisher Scientific TMO Stock Holding History

Ossiam’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.3M Buy
+68,473
New +$32.9M 0.46% 39
2025
Q4 		– Sell
-8,028
Closed -$3.89M – 678
2025
Q3 		$3.89M Buy
8,028
+555
+7% +$258K 0.05% 239
2025
Q2 		$3.03M Sell
7,473
-3,400
-31% -$1.42M 0.03% 217
2025
Q1 		$5.41M Sell
10,873
-1,222
-10% -$662K 0.08% 126
2024
Q4 		$6.29M Buy
12,095
+2,236
+23% +$1.23M 0.11% 125
2024
Q3 		$6.1M Sell
9,859
-3,698
-27% -$2.19M 0.12% 94
2024
Q2 		$7.5M Buy
13,557
+3,135
+30% +$1.8M 0.14% 91
2024
Q1 		$6.06M Buy
10,422
+1,205
+13% +$676K 0.11% 129
2023
Q4 		$4.89M Buy
9,217
+447
+5% +$216K 0.08% 122
2023
Q3 		$4.44M Sell
8,770
-27,872
-76% -$14.9M 0.08% 123
2023
Q2 		$19.1M Buy
36,642
+33,808
+1,193% +$18.2M 0.34% 69
2023
Q1 		$1.63M Sell
2,834
-56,477
-95% -$31.8M 0.03% 219
2022
Q4 		$32.7M Buy
59,311
+20,101
+51% +$10.7M 0.85% 32
2022
Q3 		$19.9M Buy
39,210
+37,898
+2,889% +$21.2M 0.58% 40
2022
Q2 		$713K Sell
1,312
-38,822
-97% -$21.4M 0.02% 258
2022
Q1 		$23.7M Buy
40,134
+11,319
+39% +$6.5M 0.62% 38
2021
Q4 		$19.2M Buy
28,815
+3,842
+15% +$2.4M 0.5% 52
2021
Q3 		$14.3M Sell
24,973
-45,720
-65% -$25.1M 0.4% 50
2021
Q2 		$38.2M Buy
70,693
+52,511
+289% +$24.8M 1.04% 21
2021
Q1 		$8.3M Buy
18,182
+17,962
+8,165% +$8.57M 0.26% 73
2020
Q4 		$102K Buy
220
+165
+300% +$77.4K ﹤0.01% 354
2020
Q3 		$24K Buy
55
+1
+2% +$413 ﹤0.01% 369
2020
Q2 		$20K Sell
54
-3,493
-98% -$1.17M ﹤0.01% 410
2020
Q1 		$1.01M Buy
3,547
+3,020
+573% +$952K 0.07% 175
2019
Q4 		$171K Buy
527
+435
+473% +$132K 0.01% 326
2019
Q3 		$27K Sell
92
-206
-69% -$59K ﹤0.01% 450
2019
Q2 		$88K Buy
+298
New +$82.1K 0.01% 387

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Ossiam's TMO Position: Q2 2026 in Review

Ossiam opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 68,473 shares worth $34.3M. The stake represents 0.46% of the portfolio and ranks #39 among its holdings. This is a return to the name: Ossiam previously reported a position in TMO as recently as Q3 2025.

Ossiam first reported a position in TMO in Q2 2019 and has held it in 27 quarters since. The position peaked at $38.2M in Q2 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Ossiam held 68,473 shares of Thermo Fisher Scientific worth $34.3M as of Q2 2026.
  • Thermo Fisher Scientific was a new Ossiam position in Q2 2026.
  • Thermo Fisher Scientific made up 0.46% of Ossiam's portfolio in Q2 2026, its #39 holding.
  • Ossiam first reported a position in Thermo Fisher Scientific in Q2 2019 and has held it in 27 quarters since.
  • Ossiam's Thermo Fisher Scientific position peaked at $38.2M in Q2 2021.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Ossiam's 13F filing for Q2 2026, filed 13 Aug 2026.